Myasthenia Gravis Treatment: Current and New Options – John Sturgis, MD As a result of participation in this educational activity, members of the healthcare team will: Determine the use of both corticosteroid and older steroid-sparing immunosuppressives in the treatment of myasthenia gravis Evaluate the newer classes of medications approved for the treatment of myasthenia gravis and treatment considerations
- Provider:University of Wisconsin-Madison Interprofessional Continuing Education Partnership
- Activity Link: https://ce.icep.wisc.edu/node/47983
- Start Date: 2024-03-16 05:00:00
- End Date: 2024-03-16 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest